Zobrazeno 1 - 10
of 260
pro vyhledávání: '"Catherine Lombard-Bohas"'
Autor:
Carole Morin, Keo-Morakort Benedetto, Agathe Deville, Laurent Milot, Aurélie Theillaumas, Valérie Hervieu, Mathieu Pioche, Gilles Poncet, Julien Forestier, Laurent François, Francoise Borson-Chazot, Mustapha Adham, Catherine Lombard-Bohas, Thomas Walter
Publikováno v:
Endocrine Connections, Vol 11, Iss 6, Pp 1-12 (2022)
Purpose: To improve neuroendocrine neoplasm (NEN) management, the European Neuroendocrine Tumor Society (ENETS) recognised 62 Centers of Excellence (CoE). This retrospective study compares conformity of patients’ initial management within vs outsid
Externí odkaz:
https://doaj.org/article/f1cee055f6674d02bee186721fd5a5ed
Autor:
Thomas Couronne, Paul Girot, Julien Hadoux, Thierry Lecomte, Alice Durand, Caroline Fine, Katia Vandevoorde, Catherine Lombard-Bohas, Thomas Walter
Publikováno v:
Endocrine Connections, Vol 9, Iss 6, Pp 498-505 (2020)
Objective: First-line chemotherapy in metastatic neuroendocrine carcinomas (NECs) is based on etoposide and platinum. However, there is no standard concerning second-line treatment. The objective of this study was to evaluate effic acy and tolerance
Externí odkaz:
https://doaj.org/article/86851713c3d2448bb59ddd470a1a72ef
Autor:
Thomas Walter, Astrid Lievre, Romain Coriat, David Malka, Farid Elhajbi, Fréderic Di Fiore, Olivia Hentic, Denis Smith, Vincent Hautefeuille, Guillaume Roquin, Marine Perrier, Laetitia Dahan, Victoire Granger, Iradj Sobhani, Laurent Mineur, Patricia Niccoli, Eric Assenat, Jean-Yves Scoazec, Karine Le Malicot, Côme Lepage, Catherine Lombard-Bohas
Publikováno v:
The Lancet Oncology. 24:297-306
Autor:
Côme Lepage, Jean-Marc Phelip, Astrid Lievre, Karine Le-Malicot, Laetitia Dahan, David Tougeron, Christos Toumpanakis, Frédéric Di-Fiore, Catherine Lombard-Bohas, Ivan Borbath, Romain Coriat, Thierry Lecomte, Rosine Guimbaud, Caroline Petorin, Jean-Louis Legoux, Pierre Michel, Jean-Yves Scoazec, Denis Smith, Thomas Walter
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩
International audience; Background: Following European guidelines, patients with aggressive metastatic or locally advanced, non-resectable, duodeno-pancreatic (DP) neuroendocrine tumours (NETs) should receive systemic combination chemotherapy until p
Autor:
Alice Schwartz, Pascale Mere, Fabien Subtil, Hélène Labrosse, Fadila Farsi, Laure Guittard, Byeul-A Kim, Géraldine Martin-Gaujard, Catherine Lombard-Bohas, Elisabeth Castel-Kremer
Publikováno v:
Bulletin du Cancer. 109:659-669
Autor:
Clémence Delhomme, Thomas Walter, Dimitri Arangalage, Gaspard Suc, Olivia Hentic, Agnès Cachier, Soleiman Alkhoder, Laurent François, Catherine Lombard‐Bohas, Bernard Iung, Philippe Ruszniewski, Louis de Mestier
Publikováno v:
Journal of Neuroendocrinology. 35
Autor:
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, Mohamad Sonbol, Rachel A Eiring, Sara Pusceddu, Natalie Prinzi, Benedetta Lombardi Stocchetti, Simona Grozinsky-Glasberg, David J Gross, Thomas Walter, Patrick Robelin, Catherine Lombard-Bohas, Samuele Frassoni, Vincenzo Bagnardi, Lorenzo Antonuzzo, Clotilde Sparano, Sara Massironi, Fabio Gelsomino, Alberto Bongiovanni, Nicoletta Ranallo, Salvatore Tafuto, Maura Rossi, Mauro Cives, Ibrahim Rasul Kakil, Hytam Hamid, Alessandra Chirco, Michela Squadroni, Anna La Salvia, Jorge Hernando, Johannes Hofland, Anna Koumarianou, Sabrina Boselli, Darina Tamayo, Cristina Mazzon, Manila Rubino, Francesca Spada
Publikováno v:
Endocrine-Related Cancer. 30
We conducted a retrospective/prospective worldwide study on patients with neuroendocrine neoplasms (NENs) and a molecularly proven SARS-CoV-2 positivity. Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021. No
Autor:
Lucie Duponchelle, Eric Baudin, Fabien Subtil, Christine Do Cao, Eric Dansin, Marine Perrier, Marie-Pierre Teissier, Magalie Haissaguerre, Xavier Cansouline, Julien Hadoux, Galina Jepiral, Catherine Lombard-Bohas, Olaf Mercier, François Tronc, Thomas Walter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::493f0bc3fb96947840eeb6b943827c8d
https://doi.org/10.2139/ssrn.4329999
https://doi.org/10.2139/ssrn.4329999
Autor:
null Clémence Delhomme, null Thomas Walter, null Dimitri Arangalage, null Gaspard Suc, null Olivia Hentic, null Agnès Cachier, null Soleiman Alkhoder, null Laurent François, null Catherine Lombard‐Bohas, null Bernard Iung, null Philippe Ruszniewski, null Louis de Mestier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe54ac8c4a9daf33dcb6ce99ecb494a1
https://doi.org/10.1111/jne.13262/v2/response1
https://doi.org/10.1111/jne.13262/v2/response1
Autor:
Julien Forestier, Philip Robinson, Catherine Lombard-Bohas, Gérald Raverot, Laurent Milot, Annie Lemelin, Françoise Borson-Chazot, Lucia Hue-Fontaine, Thomas Walter
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.954-960. ⟨10.1016/j.clinre.2020.02.011⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.954-960. ⟨10.1016/j.clinre.2020.02.011⟩
To explore potential synergy in effectiveness between metformin and everolimus, 2 inhibitors of the mTOR pathway, for neuroendocrine tumours (NET).A cohort of patients with advanced gastroenteropancreatic or lung NETs treated by everolimus were strat